Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers
- PMID: 17574839
- DOI: 10.1016/j.ejca.2007.04.023
Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers
Abstract
Ten BRCA mutations were demonstrated to be frequent in the Norwegian population. We present maps verifying the uneven distribution of prevalences according to municipality. We tested incident breast cancer cases treated in Mid-Norway from 1999 onwards for these mutations. Uptake of testing was 97% and 2.5% were demonstrated to be mutation carriers. Ten (77%) were outside families previously known to carry a mutation. Ten (77%) did not meet clinical criteria to be selected for mutation testing. We tested incident ovarian cancer cases in South-West Norway from 2001 onwards. Uptake of testing was 80% and 23% were mutation carriers. Twenty-one (88%) were outside families previously known. Twelve (67%) did not meet clinical criteria to be selected for testing. All patients with mutation collaborated actively to give our offer of predictive genetic testing to their relatives. No complaint on the activity was received.
Similar articles
-
Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles: an ascertainment bias phenomenon?Breast Cancer Res Treat. 2005 Aug;92(3):273-7. doi: 10.1007/s10549-005-3377-x. Breast Cancer Res Treat. 2005. PMID: 16155798
-
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.Cancer. 2005 Dec 15;104(12):2807-16. doi: 10.1002/cncr.21536. Cancer. 2005. PMID: 16284991
-
Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.ANZ J Surg. 2007 May;77(5):314-9. doi: 10.1111/j.1445-2197.2007.04050.x. ANZ J Surg. 2007. PMID: 17497966
-
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.J Med Genet. 2005 Mar;42(3):e20. doi: 10.1136/jmg.2004.027243. J Med Genet. 2005. PMID: 15744030 Free PMC article. Review. No abstract available.
-
Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.Minerva Med. 2009 Oct;100(5):371-83. Minerva Med. 2009. PMID: 19910890 Review.
Cited by
-
Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies.Cancers (Basel). 2022 Dec 12;14(24):6113. doi: 10.3390/cancers14246113. Cancers (Basel). 2022. PMID: 36551598 Free PMC article.
-
Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical Setting.Front Genet. 2022 Jul 22;13:881100. doi: 10.3389/fgene.2022.881100. eCollection 2022. Front Genet. 2022. PMID: 35938029 Free PMC article.
-
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot.J Med Genet. 2022 Dec;59(12):1179-1188. doi: 10.1136/jmg-2022-108655. Epub 2022 Jul 22. J Med Genet. 2022. PMID: 35868849 Free PMC article. Clinical Trial.
-
Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin.Asian Pac J Cancer Prev. 2022 Jun 1;23(6):2027-2033. doi: 10.31557/APJCP.2022.23.6.2027. Asian Pac J Cancer Prev. 2022. PMID: 35763645 Free PMC article.
-
Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland.Sci Rep. 2022 Apr 25;12(1):6704. doi: 10.1038/s41598-022-10519-y. Sci Rep. 2022. PMID: 35469032 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical